Clin Transl Allergy:鼻炎患者中的过敏性多重病症研究

2020-03-23 AlexYang MedSci原创

鼻炎是一种常见的疾病。许多鼻炎患者同时具有过敏性多重病症,比如哮喘和湿疹。最近,有研究人员对只患有鼻炎的患者和患有鼻炎,哮喘和/或湿疹的患者进行了比较,涉及了免疫球蛋白E(lgE)敏感、炎症标记、家族

鼻炎是一种常见的疾病。许多鼻炎患者同时具有过敏性多重病症,比如哮喘和湿疹。最近,有研究人员对只患有鼻炎的患者和患有鼻炎,哮喘和/或湿疹的患者进行了比较,涉及了免疫球蛋白E(lgE)敏感、炎症标记、家族历史、肺功能和身体质量指数(BMI)。

研究总共包括了216名成年鼻炎患者,并进行了多重组分过敏原分析(103中过敏原组分)。研究发现,216名鼻炎患者中,89名具有哮喘和/或湿疹。同时患有鼻炎和哮喘/湿疹的参与者更可能是lgE敏感(3.44, OR: 95% CI 1.62-7.30, 调整性别、年龄、母亲过敏、总lgE和肺活量(FEV1)后)。在调整性别、年龄、母亲过敏、总lgE和肺活量(FEV1)后,lgE阳性组分数与过敏性多重病症独立相关(1.11, OR: 95% Cl 1.01-1.21)。当分析了不同类型的敏感后,与过敏性多重病症相关性最强烈的存在于对常年和季节性过敏原均lgE敏感的参与者中(4.50, OR: 95% CI 1.61-12.5)。另外,母体过敏(2.75, OR: 95% CI 1.15-4.46)、高总lgE(2.38, OR: 95% CI 1.21-4.67)和更低的FEV1(0.73, OR: 95% CI 0.58-0.93)均与多重病症独立相关,而没有发现与其他炎症标记的相关性。

最后,研究人员指出,对常年性和季节性过敏原的lgE多重致敏和lgE水平是鼻炎患者中过敏性多重病症的主要决定因素。表明了靶向lgE敏感的治疗对减少发展为过敏性多重病症很有价值。

原始出处:

Blondal V, Sundbom F, Borres MP et al. Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis. Clin Transl Allergy. 21 Feb 2020.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2067499, encodeId=5e4d206e4991e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jan 19 05:14:34 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657303, encodeId=e983165e303a4, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Jul 28 18:14:34 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047240, encodeId=ac96204e2403a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Apr 27 03:14:34 CST 2020, time=2020-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329355, encodeId=d0041329355a2, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Mar 25 03:14:34 CST 2020, time=2020-03-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2067499, encodeId=5e4d206e4991e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jan 19 05:14:34 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657303, encodeId=e983165e303a4, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Jul 28 18:14:34 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047240, encodeId=ac96204e2403a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Apr 27 03:14:34 CST 2020, time=2020-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329355, encodeId=d0041329355a2, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Mar 25 03:14:34 CST 2020, time=2020-03-25, status=1, ipAttribution=)]
    2020-07-28 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=2067499, encodeId=5e4d206e4991e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jan 19 05:14:34 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657303, encodeId=e983165e303a4, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Jul 28 18:14:34 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047240, encodeId=ac96204e2403a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Apr 27 03:14:34 CST 2020, time=2020-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329355, encodeId=d0041329355a2, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Mar 25 03:14:34 CST 2020, time=2020-03-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2067499, encodeId=5e4d206e4991e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jan 19 05:14:34 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657303, encodeId=e983165e303a4, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Jul 28 18:14:34 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047240, encodeId=ac96204e2403a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Apr 27 03:14:34 CST 2020, time=2020-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329355, encodeId=d0041329355a2, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Wed Mar 25 03:14:34 CST 2020, time=2020-03-25, status=1, ipAttribution=)]
    2020-03-25 膀胱癌

相关资讯

BMC Pediatr:儿童过敏性疾病发生的产前和新生儿因素研究

过敏性疾病,比如哮喘、皮炎、鼻炎和湿疹在中国学龄儿童中高度流行。环境因素,包括空气污染和汽车废气在这些疾病的病因中具有重要的作用。然而,产前和新生儿因素,包括性别、母亲怀孕期间疾病和早产,可能也于过敏性疾病的发生有关。最近,有研究人员在中国广州的小学和中学学生中,探索了与过敏性疾病相关的产前和新生儿因素。研究基于183449份调查问卷和医疗记录。数据表明,性别、出生体重、新生儿喂养类型、出生方法和

Int Arch Allergy Immunol:儿童和青少年中桃树花粉和水蜜桃9敏感和过敏研究

尽管植物和水果花粉是虫媒的且和接触的工人有关,研究人员展示了在桃树栽培地区的成年人中,桃树花粉(PTP)和水蜜桃9(Pru 9)的致敏和诱导症状情况。研究人员在年龄为3-19岁的一个大的群体中研究了PTP和Pru9的致敏和临床相关向情况,并进行了详细的调查问卷和皮刺测试来调查相关的过敏原、PTP和Pru9,并通过鼻激发测试(NPT)和症状评分指数探究临床相关性情况。研究人员共评估了685名儿童(平

如何进行过敏原检测?

过敏已经成为一种全球性的富贵病,20%—40%的人一生中都曾罹患过敏性疾病,包括过敏性鼻炎、支气管哮喘、急性荨麻疹、婴儿湿疹、接触性皮炎、食物/药物过敏、过敏性休克等,其中过敏性休克是最致命的。

Pediatr Allergy Immunol:早期接触猫和狗以及家畜与儿童哮喘和过敏的关系研究

怀孕期间接触猫、狗和家畜对儿童哮喘和过敏的协同作用情况仍旧不清楚。最近,有研究人员调查了儿童在5岁之前,怀孕期间接触室内宠物与家畜与哮喘和过敏风险之间的独立相关性和协同相关性情况。研究包括了3781名儿童。这些儿童在5岁的时候进行国际儿童哮喘和过敏调查问卷,从而搜集关于哮喘和过敏性疾病情况以及1岁的时候接触室内宠物与家畜的情况。研究发现,家中养狗与哮喘风险(HR 0.60; 95%CI, 0.38

Otolaryngol Head Neck Surg:儿科过敏性呼吸道疾病造成的认知和生活质量相关负担研究

最近,有研究人员分析了儿科呼吸道过敏性疾病(PAA)的患病率情况,并分析了其对认知功能、儿童活动、早期干预和缺课情况的影响。

Allergy:鼻上皮障碍功能的异常能够增加致敏和肥大细胞的脱粒作用

上皮通透性的增加在过敏性鼻炎中已有报道,且组胺和2型炎症对紧密连接功能障碍具有影响。上皮障碍的缺陷对过敏性致敏和肥大细胞(MC)脱粒作用的影响仍旧未知。最近,有研究人员发现,在培养的原代鼻上皮细胞中,壳聚糖能够强烈的减少跨膜电阻,并促进经皮过敏原的传输。体内试验中,壳聚糖能够影响闭锁蛋白表达,并促进过敏原的传输。上皮障碍功能异常后,鼻内OVA能够诱导更高的血清中OVA特异性lgG1水平和lgE水平